James E. Moon

1.8k total citations
20 papers, 531 citations indexed

About

James E. Moon is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Parasitology. According to data from OpenAlex, James E. Moon has authored 20 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 5 papers in Public Health, Environmental and Occupational Health and 5 papers in Parasitology. Recurrent topics in James E. Moon's work include Leptospirosis research and findings (5 papers), Viral Infections and Vectors (5 papers) and Mosquito-borne diseases and control (3 papers). James E. Moon is often cited by papers focused on Leptospirosis research and findings (5 papers), Viral Infections and Vectors (5 papers) and Mosquito-borne diseases and control (3 papers). James E. Moon collaborates with scholars based in United States, United Kingdom and Thailand. James E. Moon's co-authors include James F. Cummings, Valerian B. Pinto, Wendell D. Zollinger, Paul B. Keiser, Deborah H. Schmiel, Robert A. Bowden, Elizabeth Morán, Duane R. Hospenthal, Clinton K. Murray and Joshua S. Hawley and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, SLEEP and Journal of Antimicrobial Chemotherapy.

In The Last Decade

James E. Moon

20 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James E. Moon United States 12 189 159 108 105 89 20 531
Jill Vaughan Australia 14 163 0.9× 252 1.6× 103 1.0× 77 0.7× 70 0.8× 31 560
Anja Berger Germany 16 133 0.7× 211 1.3× 34 0.3× 51 0.5× 54 0.6× 36 542
Bettina Sallé Gabon 9 51 0.3× 138 0.9× 44 0.4× 27 0.3× 38 0.4× 12 496
Linnie M. Golightly United States 17 134 0.7× 181 1.1× 154 1.4× 67 0.6× 460 5.2× 30 820
Todd M. Bell United States 16 366 1.9× 215 1.4× 85 0.8× 9 0.1× 89 1.0× 27 574
Francisco Gutiérrez Díez Spain 5 132 0.7× 173 1.1× 33 0.3× 35 0.3× 34 0.4× 15 412
Terri Moore United States 9 51 0.3× 193 1.2× 50 0.5× 257 2.4× 22 0.2× 10 623
Juliana Pinto da Silva Mol Brazil 15 39 0.2× 229 1.4× 86 0.8× 18 0.2× 38 0.4× 40 746
Pia Zimmermann Germany 11 143 0.8× 127 0.8× 152 1.4× 22 0.2× 30 0.3× 19 446
Barthélémy Ngoubangoye Gabon 14 114 0.6× 157 1.0× 82 0.8× 10 0.1× 267 3.0× 59 714

Countries citing papers authored by James E. Moon

Since Specialization
Citations

This map shows the geographic impact of James E. Moon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Moon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Moon more than expected).

Fields of papers citing papers by James E. Moon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Moon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Moon. The network helps show where James E. Moon may publish in the future.

Co-authorship network of co-authors of James E. Moon

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Moon. A scholar is included among the top collaborators of James E. Moon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Moon. James E. Moon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hooper, Jay W., Steven A. Kwilas, Matthew Josleyn, et al.. (2024). Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injection. npj Vaccines. 9(1). 221–221. 4 indexed citations
2.
Paolino, Kristopher, Jason A. Regules, James E. Moon, et al.. (2022). Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adults. Vaccine. 40(12). 1864–1871. 14 indexed citations
3.
Moon, James E., Jason A. Regules, Muriel Debois, et al.. (2021). A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01E in a controlled human malaria infection challenge. Vaccine. 39(43). 6398–6406. 7 indexed citations
4.
Froude, Jeffrey W., Óscar Cabrera, Matthew R. Scherer, et al.. (2021). Cross-Cutting Lessons Learned During the COVID-19 Pandemic—the Walter Reed Army Institute of Research Experience. Military Medicine. 188(1-2). 158–165. 2 indexed citations
5.
Labbé, Geneviève M., Kazutoyo Miura, Sarah E. Silk, et al.. (2019). Harmonization study between three laboratories for expression of malaria vaccine clinical trial IgG antibody ELISA data in µg/mL. Malaria Journal. 18(1). 300–300. 2 indexed citations
6.
Danko, Janine, Tadeusz J. Kochel, Nimfa Teneza-Mora, et al.. (2018). Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial. American Journal of Tropical Medicine and Hygiene. 98(3). 849–856. 64 indexed citations
7.
Doty, Tracy Jill, Angela M. Yarnell, Vincent F. Capaldi, et al.. (2017). Limited Efficacy of Caffeine and Recovery Costs During and Following 5 Days of Chronic Sleep Restriction. SLEEP. 40(12). 25 indexed citations
8.
Ramakrishnan, Sridhar, Nancy J. Wesensten, Gary H. Kamimori, et al.. (2016). A Unified Model of Performance for Predicting the Effects of Sleep and Caffeine. SLEEP. 39(10). 1827–1841. 31 indexed citations
9.
Morasch, Katherine C., et al.. (2014). Physiological and neurobehavioral effects of cholinesterase inhibition in healthy adults. Physiology & Behavior. 138. 165–172. 12 indexed citations
10.
Hooper, Jay W., James E. Moon, Kristopher Paolino, et al.. (2014). A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation. Clinical Microbiology and Infection. 20. 110–117. 50 indexed citations
11.
12.
Kuschner, Robert A., Kevin L. Russell, Dennis J. Faix, et al.. (2013). A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits. Vaccine. 31(28). 2963–2971. 53 indexed citations
13.
14.
Moon, James E., Gregory A. Deye, Raymond Miller, et al.. (2011). Plasmodium falciparum Infection during Suppressive Prophylaxis with Mefloquine Does Not Induce an Antibody Response to Merozoite Surface Protein-1(42). American Journal of Tropical Medicine and Hygiene. 84(5). 825–829. 4 indexed citations
15.
Rivard, Robert G., Matthew E. Griffith, Joshua S. Hawley, et al.. (2007). Efficacy of caspofungin and posaconazole in a murine model of disseminatedExophialainfection. Medical Mycology. 45(8). 685–689. 14 indexed citations
16.
Griffith, Matthew E., James E. Moon, Erica Johnson, et al.. (2007). Efficacy of Fluoroquinolones againstLeptospira interrogansin a Hamster Model. Antimicrobial Agents and Chemotherapy. 51(7). 2615–2617. 21 indexed citations
17.
Griffith, Matthew E., Lynn L. Horvath, Joshua S. Hawley, et al.. (2006). Viability of Leptospira in BacT/ALERT® MB Media. Diagnostic Microbiology and Infectious Disease. 54(4). 263–266. 11 indexed citations
18.
Moon, James E., Robert G. Rivard, M. Griffith, et al.. (2006). Effect of timing and duration of azithromycin therapy of leptospirosis in a hamster model. Journal of Antimicrobial Chemotherapy. 59(1). 148–151. 9 indexed citations
19.
Moon, James E., Michael W. Ellis, Matthew E. Griffith, et al.. (2006). Efficacy of Macrolides and Telithromycin against Leptospirosis in a Hamster Model. Antimicrobial Agents and Chemotherapy. 50(9). 3231–3231. 2 indexed citations
20.
Moon, James E., Michael C. Ellis, Matthew E. Griffith, et al.. (2006). Efficacy of Macrolides and Telithromycin against Leptospirosis in a Hamster Model. Antimicrobial Agents and Chemotherapy. 50(6). 1989–1992. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jill Vaughan Breakdown of academic impact, for papers by Anja Berger Breakdown of academic impact, for papers by Bettina Sallé Breakdown of academic impact, for papers by Linnie M. Golightly Breakdown of academic impact, for papers by Todd M. Bell Breakdown of academic impact, for papers by Francisco Gutiérrez Díez Breakdown of academic impact, for papers by Terri Moore Breakdown of academic impact, for papers by Juliana Pinto da Silva Mol Breakdown of academic impact, for papers by Pia Zimmermann Breakdown of academic impact, for papers by Barthélémy Ngoubangoye
Rankless by CCL
2026